Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway
Condition(s):Castration-resistant Prostate Cancer; MetastasisLast Updated:April 30, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):Castration-resistant Prostate Cancer; MetastasisLast Updated:April 30, 2021Terminated
Condition(s):Castration-resistant Prostate Cancer; Androgen Deprivation TherapyLast Updated:April 20, 2021Completed
Condition(s):Prostate Cancer MetastaticLast Updated:November 14, 2014Completed
Condition(s):Prostate Cancer MetastaticLast Updated:March 13, 2024Recruiting
Condition(s):Castration-resistant Prostate CancerLast Updated:July 22, 2020Recruiting
Condition(s):Metastatic Prostate Cancer; Castration-resistant Prostate CancerLast Updated:July 23, 2020Recruiting
Condition(s):Prostate CancerLast Updated:March 5, 2024Active, not recruiting
Condition(s):Prostate Cancer; Castration-resistant Prostate Cancer; Metastatic Prostate CancerLast Updated:March 4, 2021Completed
Condition(s):Prostatic NeoplasmsLast Updated:July 12, 2019Completed
Condition(s):Metastatic Castration-resistant Prostate Cancer (CRPCa)Last Updated:January 11, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.